Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
logo icon CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Convalife and Medicilon announced a strategic pact to jointly conduct preclinical research

2020-06-30
|
Page View:

Chuansha, Shanghai, June 29, 2020. — Convalife and Medicilon signed a strategic pact, initiating a long-term cooperation between the two companies.

Convalife and Medicilon

Based on previous cooperation and the mutual trust, Medicilon and Convalife achieved consensus on the partnership that Medicilon will assist Convalife in new drug development utilizing its integrated pharmaceutical R&D service platform. According to the pact, Convalife will deeply cooperate with Medicilon on multiple projects of their “First-in-Class” or “Best-in-Class” new drug R&D. The cooperation is anticipated to accelerate the process of new drug development and IND filing, to offer better solutions for unsatisfied clinical requirements worldwide.

Return
Relevant newsRelevant news